1. FDA approves new mRNA COVID vaccines targeting the KP.2 variant

2. Annual vaccination recommended for everyone 6 months and older

3. Vaccines offer protection against infection and reduce transmission

4. Effectiveness declines after about 4 months; may help reduce long COVID risk

5. Available at pharmacies and doctor's offices; timing depends on personal factors